FINNENCE ▪ THE WIRE FILE
THE WIRE · № 67519
News■ Unclear/unknown
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-06 15:27 UTC
LAST UPDATE2026-10-06 15:27 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Commercial release of an FDA-approved device affects an ASX-listed firm not in the allowed slug list.
Medtech launch outside covered tickers
CATALYST TO WATCH
US sales ramp disclosure
MAIN RISK
Adoption slower than commercial rollout
FULL DISPATCH
BLOOMINGTON, Minn., Oct. 6, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company") a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
←CORRELATIONshares Healthcare
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms2026-10-06 08:21 UTC
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms2026-10-06 08:21 UTC
←CORRELATIONshares Healthcare
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ)2026-10-06 12:33 UTC
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ)2026-10-06 12:33 UTC
←CORRELATIONshares Healthcare
Aesthetic Management Partners Introduces Cellenis® Exo-ME™, Bringing Autologous Extracellular Vesicle Technology to the Skin Booster Market2026-10-06 13:30 UTC
Aesthetic Management Partners Introduces Cellenis® Exo-ME™, Bringing Autologous Extracellular Vesicle Technology to the Skin Booster Market2026-10-06 13:30 UTC
←CORRELATIONshares Healthcare
Washington State Expands No-Cost Support for Rural Family Caregivers Through Trualta2026-10-06 14:00 UTC
Washington State Expands No-Cost Support for Rural Family Caregivers Through Trualta2026-10-06 14:00 UTC
←CORRELATIONshares Healthcare
A $1B special dividend features in Indivior (INDV)'s revised merger valuation details.2026-10-06 14:10 UTC
A $1B special dividend features in Indivior (INDV)'s revised merger valuation details.2026-10-06 14:10 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.